Saturn V Capital Management »

Oculis Holding shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Oculis Holding (OCS) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Oculis Holding

Tip: Access up to 7 years of quarterly data

All positions including Oculis Holding held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oculis Holding by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $10M 517k 19.97

More positions owned by Saturn V Capital Management

Abivax Sa Sponsored Ads (ABVX)
Amylyx Pharmaceuticals (AMLX)
Cogent Biosciences (COGT)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Vaxcyte (PCVX)
Dyne Therapeutics (DYN)
Pharvaris N V (PHVS)
Celcuity (CELC)
Alumis (ALMS)
Disc Medicine (IRON)
X4 Pharmaceuticals Com New (XFOR)
Monopar Therapeutics Com New (MNPR)
Adagio Therapeutics (IVVD)
Ocular Therapeutix (OCUL)
Immix Biopharma (IMMX)

View all positions for Saturn V Capital Management

Top funds holding Oculis Holding

EQT Fund Management S.a r.l.
Gildi - lifeyrissjodur
Pivotal bioVenture Partners Investment Advisor
Standard Life Aberdeen
Sr One Capital Management
Saturn V Capital Management
Nan Fung Group Holdings
Alyeska Investment Group
Woodline Partners
Syquant Capital Sas
Folketrygdfondet
Propel Bio Management
Compagnie Lombard, Odier SCA
Longwood Capital Partners
Simplify Asset Management

View all funds holding Oculis Holding